Key regions: Australia, Italy, France, South Korea, Brazil
Uganda is a country that is known for its diverse wildlife, including the famous mountain gorillas. However, the healthcare industry in Uganda has also been growing steadily in recent years, including the vaccines market.
Customer preferences: The Ugandan population has become more aware of the importance of immunization and disease prevention, leading to an increase in demand for vaccines. This is especially true for children, as parents are more willing to vaccinate their children against diseases such as measles, polio, and tuberculosis.
Trends in the market: The vaccines market in Uganda has been growing steadily, with an increasing number of vaccines being introduced in the country. There has been a particular focus on vaccines for children, with the government implementing various immunization programs to increase vaccination rates. In addition, there has been an increased demand for vaccines for diseases such as yellow fever and meningitis due to outbreaks in neighboring countries.
Local special circumstances: One of the challenges facing the vaccines market in Uganda is the lack of infrastructure and resources in some regions of the country. This can make it difficult to distribute vaccines to remote areas, leading to lower vaccination rates in these areas. In addition, there is also a lack of awareness and education about the importance of vaccines in some communities, which can lead to vaccine hesitancy.
Underlying macroeconomic factors: Uganda's economy has been growing steadily in recent years, which has led to an increase in healthcare spending. The government has also been investing in the healthcare sector, including the vaccines market. In addition, Uganda has received support from international organizations such as the World Health Organization and Gavi, the Vaccine Alliance, which has helped to improve access to vaccines in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
